Cat. #153995
Anti-VLDL [5F3]
Cat. #: 153995
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 10-12 weeks
Target: Very low density lipoprotein receptor
Class: Monoclonal
Application: WB ; ELISA
Reactivity: Human
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Institute: University of Maryland
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-VLDL [5F3]
- Alternate name: VLDL receptor
- Research fields: Cell signaling and signal transduction;Genetics;Neurobiology
- Tool sub type: Primary antibody
- Class: Monoclonal
- Purpose: Marker
- Conjugation: Unconjugated
- Molecular weight: 96 kDa
- Reactivity: Human
- Host: Mouse
- Application: WB ; ELISA
- Description: The LDLR family is composed of several cell-surface proteins including VLDL. This receptor has been shown to interact with apoE, a process that is inhibited by RAP. Like LRP, VLDL is expressed within the brain with mutations in the protein leading to neurological disorders.
- Immunogen: recombinant sVLDLr1-8
- Isotype: IgG1
Target Details
- Target: Very low density lipoprotein receptor
- Molecular weight: 96 kDa
- Tissue cell line specificity: Mouse
- Target background: The LDLR family is composed of several cell-surface proteins including VLDL. This receptor has been shown to interact with apoE, a process that is inhibited by RAP. Like LRP, VLDL is expressed within the brain with mutations in the protein leading to neurological disorders.
Applications
- Application: WB ; ELISA
Handling
- Format: Liquid
- Unit size: 100 ug
- Shipping conditions: Dry ice
References
- Ruiz et al. 2005. J Lipid Res. 46(8):1721-31. PMID: 15863833.
- The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor.
